Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Dec 27, 2023
Date Accepted: May 13, 2024

The final, peer-reviewed published version of this preprint can be found here:

Implementation of Patient-Reported Outcomes in a Medical Oncology Setting (the iPROMOS Study): Type II Hybrid Implementation Study

Roberts NA, Pelecanos A, Alexander K, Wyld D, Janda M

Implementation of Patient-Reported Outcomes in a Medical Oncology Setting (the iPROMOS Study): Type II Hybrid Implementation Study

J Med Internet Res 2024;26:e55841

DOI: 10.2196/55841

PMID: 39190468

PMCID: 11387919

Do patient reported outcomes in routine oncology care improve symptom detection: A type II hybrid implementation study (The iPROMOS study)

  • Natasha Anne Roberts; 
  • Anita Pelecanos; 
  • Kim Alexander; 
  • David Wyld; 
  • Monika Janda

ABSTRACT

Background:

Clinical trials have demonstrated that patient reported outcome measures (PROMs) have been identified to improve mortality and morbidity outcomes when used in clinical practice. This study aimed to prospectively investigate implementation of patient reported outcome measures (PROMs) in routine oncology.

Objective:

Outcomes aimed to measure improved symptom detection, clinical response to symptom information and health service outcomes.

Methods:

Two clinics were randomised to implement symptom PROMs in a medical oncology outpatient department in Australia. Randomisation was done at the level of clinic. Patients in control clinics continued with usual care; patients in intervention clinics completed a symptom PROM at presentation. The main outcome of interest was symptom detection, using binary logistic models, and clinical response to PROMs investigated using multiple regression models.

Results:

A total of 461 patient encounters were included, consisting of 242 encounters in the control and 222 in the intervention condition. Patients in these clinics most commonly had head and neck, lung, prostate, breast or colorectal cancers, and were seen in the clinic for surveillance, oral or systemic treatments for curative, metastatic or palliative cancer care pathways. Compared to control encounters, symptom detection improved in intervention encounters (OR 1.05, 0.99-1.11, p=0.08).The odds of receiving supportive care, demonstrated by non-routine allied health review, increased in the intervention compared to control encounters (odds ratio 3.54, 95% confidence interval 1.26 – 9.90; p=0.02).

Conclusions:

Implementation of PROMs in routine care did not significantly improve symptom detection but increased the likelihood of non-routine allied health reviews for supportive care. Further studies with a greater number of clinics are needed to investigate health service outcomes. Clinical Trial: The study is registered on the Australia New Zealand Clinical Trials Register, registration number ACTRN12618000398202 (https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=374630) on 05 March 2018


 Citation

Please cite as:

Roberts NA, Pelecanos A, Alexander K, Wyld D, Janda M

Implementation of Patient-Reported Outcomes in a Medical Oncology Setting (the iPROMOS Study): Type II Hybrid Implementation Study

J Med Internet Res 2024;26:e55841

DOI: 10.2196/55841

PMID: 39190468

PMCID: 11387919

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.